How many SC 13D/A filings has Tyra Biosciences, Inc. filed?

Tyra Biosciences, Inc. (TYRA) has 8 SC 13D/A (SC 13D/A) filings on record, spanning Feb 2024 to Dec 2024.

What is a SC 13D/A filing?

A SC 13D/A is an SEC filing known as "SC 13D/A." It is filed with the SEC as a SC 13D/A.

Where can I read Tyra Biosciences, Inc. SC 13D/A filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Tyra Biosciences, Inc. SC 13D/A filings, including risk assessment, sentiment analysis, and key financial figures.

Tyra Biosciences, Inc. (TYRA) — SC 13D/A Filings

All SC 13D/A filings from Tyra Biosciences, Inc.. Browse 8 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (8)

Boxer Capital Amends Tyra Biosciences Stake Filing — Dec 6, 2024 Risk: medium
Boxer Capital Management, LLC, along with Aaron I. Davis and MVA Investors, LLC, filed an amendment (No. 6) to their Schedule 13D on December 6, 2024, regarding
Boxer Capital Amends Tyra Biosciences Stake — Nov 19, 2024 Risk: medium
Boxer Capital Management, LLC, along with Aaron I. Davis and MVA Investors, LLC, filed an amendment (No. 5) to their Schedule 13D on November 19, 2024, concerni
RA Capital Amends Tyra Biosciences Stake — Nov 13, 2024 Risk: medium
RA Capital Management, L.P. and Peter Kolchinsky, through RA Capital Healthcare Fund, L.P., have amended their Schedule 13D filing for Tyra Biosciences, Inc. on
RA Capital Amends Tyra Biosciences Stake — Oct 22, 2024 Risk: medium
RA Capital Management, L.P. and its affiliates, including Peter Kolchinsky and RA Capital Healthcare Fund, L.P., have filed an amendment (No. 2) to their Schedu
Boxer Capital Amends Tyra Biosciences Stake — Oct 22, 2024 Risk: medium
Boxer Capital Management, LLC, along with its affiliates Aaron I. Davis and MVA Investors, LLC, filed an amendment (No. 4) to their Schedule 13D on October 22,
Boxer Asset Management amends Tyra Biosciences stake — Oct 15, 2024 Risk: medium
Boxer Asset Management Inc. has amended its Schedule 13D filing for Tyra Biosciences, Inc. on October 15, 2024. The filing indicates a change in beneficial owne
Boxer Capital Amends Tyra Biosciences Stake, Ownership Group Detailed — Feb 8, 2024 Risk: low
Boxer Capital, LLC, along with its affiliates like Boxer Asset Management Inc. and MVA Investors, LLC, filed an Amendment No. 2 to their Schedule 13D for Tyra B
RA Capital Amends Tyra Biosciences Stake, Kolchinsky Joins Group — Feb 6, 2024
RA Capital Management, L.P., a major institutional investor, filed an amended Schedule 13D/A on February 6, 2024, regarding its ownership in Tyra Biosciences, I

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX